Quality of Life Evaluation (SF-36) in Patients With Permanent Hypoparathyroidism After Total Thyroidectomy (Qol-Hypopara)
Quality of Life Evaluation (SF-36) in Patients With Permanent Hypoparathyroidism After Total Thyroidectomy
Sponsor: Central Hospital, Nancy, France
Listed as NCT04053647, this observational or N/A phase trial focuses on Hypoparathyroidism and Quality of Life and remains completed. Sponsored by Central Hospital, Nancy, France, it has been updated 9 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Oct 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Oct 2021 [monthly]
Completed
-
Sep 2020 — Jan 2021 [monthly]
Completed
Status: Recruiting → Completed
▶ Show 4 earlier versions
-
May 2020 — Sep 2020 [monthly]
Recruiting
-
Mar 2020 — May 2020 [monthly]
Recruiting
-
Dec 2019 — Mar 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2019 — Dec 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Central Hospital, Nancy, France
- Centre Hospitalier le Mans
- Nantes University Hospital
- Pitié-Salpêtrière Hospital
- University Hospital, Angers
- University Hospital, Limoges
For direct contact, visit the study record on ClinicalTrials.gov .